Farzaneh Salem

527 total citations
21 papers, 377 citations indexed

About

Farzaneh Salem is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, Farzaneh Salem has authored 21 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pediatrics, Perinatology and Child Health, 6 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in Farzaneh Salem's work include Pharmaceutical studies and practices (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Farzaneh Salem is often cited by papers focused on Pharmaceutical studies and practices (8 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). Farzaneh Salem collaborates with scholars based in United Kingdom, United States and Poland. Farzaneh Salem's co-authors include Amin Rostami‐Hodjegan, Trevor N. Johnson, Khaled Abduljalil, Geoffrey T. Tucker, Zoe Barter, J. Steven Leeder, Sebastian Polak, Manoranjenni Chetty, Kosuke Doki and Yoshiteru Kamiyama and has published in prestigious journals such as Advanced Drug Delivery Reviews, Clinical Pharmacokinetics and Archives of Disease in Childhood.

In The Last Decade

Farzaneh Salem

19 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farzaneh Salem United Kingdom 9 196 119 90 46 34 21 377
Yeruk Mulugeta United States 11 369 1.9× 126 1.1× 122 1.4× 44 1.0× 54 1.6× 19 595
Feras Khalil Germany 8 124 0.6× 100 0.8× 86 1.0× 43 0.9× 19 0.6× 13 320
Bianca D. van Groen Netherlands 11 240 1.2× 149 1.3× 99 1.1× 133 2.9× 28 0.8× 18 411
Ann Pariente‐Khayat France 11 158 0.8× 129 1.1× 108 1.2× 58 1.3× 24 0.7× 17 428
Amita Pansari United Kingdom 11 150 0.8× 60 0.5× 68 0.8× 45 1.0× 39 1.1× 19 337
Valvanera Vozmediano United States 11 85 0.4× 43 0.4× 51 0.6× 18 0.4× 25 0.7× 44 332
Paola Mian Netherlands 13 168 0.9× 69 0.6× 74 0.8× 34 0.7× 40 1.2× 50 460
Felix Stader Switzerland 14 123 0.6× 111 0.9× 57 0.6× 52 1.1× 12 0.4× 39 455
GJ Burckart United States 10 247 1.3× 101 0.8× 64 0.7× 91 2.0× 38 1.1× 13 581
Shareen Cox United States 15 199 1.0× 85 0.7× 138 1.5× 53 1.2× 64 1.9× 30 632

Countries citing papers authored by Farzaneh Salem

Since Specialization
Citations

This map shows the geographic impact of Farzaneh Salem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farzaneh Salem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farzaneh Salem more than expected).

Fields of papers citing papers by Farzaneh Salem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farzaneh Salem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farzaneh Salem. The network helps show where Farzaneh Salem may publish in the future.

Co-authorship network of co-authors of Farzaneh Salem

This figure shows the co-authorship network connecting the top 25 collaborators of Farzaneh Salem. A scholar is included among the top collaborators of Farzaneh Salem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farzaneh Salem. Farzaneh Salem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abduljalil, Khaled, Maïlys De Sousa Mendes, Farzaneh Salem, Sihem Benaboud, & Iain Gardner. (2025). Application of a Physiologically Based Pharmacokinetic Approach to Predict Tenofovir Pharmacokinetics During Pregnancy. The AAPS Journal. 27(1). 43–43.
2.
Stamatopoulos, Konstantinos, et al.. (2025). Physiologically Based Pharmacokinetic Modeling of Phosphate Prodrugs─Case Studies: Fostemsavir and Fostamatinib. Molecular Pharmaceutics. 22(4). 2168–2181. 1 indexed citations
3.
Thakur, Kanika, et al.. (2024). Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application. British Journal of Clinical Pharmacology. 90(6). 1428–1449. 2 indexed citations
4.
Vannappagari, Vani, Scott McCallister, Mark Bush, et al.. (2024). Responding to the Call to Action: Framework to Accelerate Clinical Data Generation for Antiretroviral Use in Pregnant Individuals with HIV. Infectious Diseases and Therapy. 13(7). 1391–1398. 3 indexed citations
5.
Salem, Farzaneh, Dung N. Nguyen, Mark Bush, et al.. (2024). Development of a physiologically based pharmacokinetic model of fostemsavir and its pivotal application to support dosing in pregnancy. CPT Pharmacometrics & Systems Pharmacology. 13(11). 1881–1892. 4 indexed citations
6.
Salem, Farzaneh, et al.. (2023). Physiologically based pharmacokinetic modeling for development and applications of a virtual celiac disease population using felodipine as a model drug. CPT Pharmacometrics & Systems Pharmacology. 12(6). 808–820. 4 indexed citations
7.
Salem, Farzaneh, Ben G. Small, & Trevor N. Johnson. (2022). Development and application of a pediatric mechanistic kidney model. CPT Pharmacometrics & Systems Pharmacology. 11(7). 854–866. 14 indexed citations
8.
Patel, Nikunjkumar, James F. Clarke, Farzaneh Salem, et al.. (2022). Multi‐phase multi‐layer mechanistic dermal absorption (MPML MechDermA) model to predict local and systemic exposure of drug products applied on skin. CPT Pharmacometrics & Systems Pharmacology. 11(8). 1060–1084. 19 indexed citations
9.
Yao, Xueting, Xuanlin Liu, Xiaobei Li, et al.. (2021). Development of a Virtual Chinese Pediatric Population Physiological Model Targeting Specific Metabolism and Kidney Elimination Pathways. Frontiers in Pharmacology. 12. 648697–648697. 4 indexed citations
10.
Hassanzad, Maryam, et al.. (2020). Potential drug-drug interactions in hospitalized pediatric patients with respiratory disorders: a retrospective review of clinically important interactions. Drug Metabolism and Personalized Therapy. 0(0). 4 indexed citations
11.
12.
Chetty, Manoranjenni, Trevor N. Johnson, Sebastian Polak, et al.. (2018). Physiologically based pharmacokinetic modelling to guide drug delivery in older people. Advanced Drug Delivery Reviews. 135. 85–96. 45 indexed citations
13.
Salem, Farzaneh, Khaled Abduljalil, Yoshiteru Kamiyama, & Amin Rostami‐Hodjegan. (2016). Considering Age Variation When Coining Drugs as High versus Low Hepatic Extraction Ratio. Drug Metabolism and Disposition. 44(7). 1099–1102. 32 indexed citations
14.
Salem, Farzaneh, Trevor N. Johnson, & Amin Rostami‐Hodjegan. (2015). MAPPING IN VITRO AND IN VIVO DERIVED CYP2C9 AND CYP2C19 ONTOGENY FUNCTIONS: A CRITICAL COMPARISON BETWEEN VARIOUS ONTOGENY MODELS. Archives of Disease in Childhood. 101(1). e1.38–e1. 1 indexed citations
15.
Salem, Farzaneh, Trevor N. Johnson, Khaled Abduljalil, Geoffrey T. Tucker, & Amin Rostami‐Hodjegan. (2014). A Re-evaluation and Validation of Ontogeny Functions for Cytochrome P450 1A2 and 3A4 Based on In Vivo Data. Clinical Pharmacokinetics. 53(7). 625–636. 107 indexed citations
16.
Salem, Farzaneh, Amin Rostami‐Hodjegan, & Trevor N. Johnson. (2013). Do Children Have the Same Vulnerability to Metabolic Drug–Drug Interactions as Adults? A Critical Analysis of the Literature. The Journal of Clinical Pharmacology. 53(5). 559–566. 37 indexed citations
17.
Salem, Farzaneh, Kayode Ogungbenro, Pavan Vajjah, et al.. (2013). Precision criteria to derive sample size when designing pediatric pharmacokinetic studies: Which measure of variability should be used?. The Journal of Clinical Pharmacology. 54(3). 311–317. 2 indexed citations
18.
Salem, Farzaneh, Trevor N. Johnson, Zoe Barter, J. Steven Leeder, & Amin Rostami‐Hodjegan. (2013). Age Related Changes in Fractional Elimination Pathways for Drugs: Assessing the Impact of Variable Ontogeny on Metabolic Drug-Drug Interactions. The Journal of Clinical Pharmacology. 53(8). 857–865. 52 indexed citations
19.
Salem, Farzaneh, et al.. (2012). A critical comparison between CYP1A2 and 3A4 ontogeny profiles used in pediatric PBPK models. Research Explorer (The University of Manchester).
20.
Khalilzadeh, Soheila, et al.. (2007). Dental Caries-Associated Microorganisms in Asthmatic Children. 6(4). 42–46. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yeruk Mulugeta Breakdown of academic impact, for papers by Feras Khalil Breakdown of academic impact, for papers by Bianca D. van Groen Breakdown of academic impact, for papers by Ann Pariente‐Khayat Breakdown of academic impact, for papers by Amita Pansari Breakdown of academic impact, for papers by Valvanera Vozmediano Breakdown of academic impact, for papers by Paola Mian Breakdown of academic impact, for papers by Felix Stader Breakdown of academic impact, for papers by GJ Burckart Breakdown of academic impact, for papers by Shareen Cox
Rankless by CCL
2026